A detailed history of Ubs Group Ag transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Group Ag holds 309,186 shares of EXAS stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
309,186
Previous 429,145 27.95%
Holding current value
$18 Million
Previous $18.1 Million 16.11%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $5.09 Million - $8.5 Million
-119,959 Reduced 27.95%
309,186 $21.1 Million
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $6.91 Million - $12.4 Million
167,214 Added 63.84%
429,145 $18.1 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $2.59 Million - $3.4 Million
46,107 Added 21.36%
261,931 $18.1 Million
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $453,876 - $581,908
-7,685 Reduced 3.44%
215,824 $16 Million
Q3 2023

Nov 09, 2023

BUY
$65.94 - $99.04 $1.75 Million - $2.62 Million
26,485 Added 13.44%
223,509 $15.2 Million
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $3.45 Million - $5.23 Million
55,027 Added 38.75%
197,024 $18.5 Million
Q1 2023

May 12, 2023

SELL
$47.19 - $70.77 $7.54 Million - $11.3 Million
-159,691 Reduced 52.93%
141,997 $9.63 Million
Q4 2022

Feb 08, 2023

BUY
$30.35 - $53.15 $4.36 Million - $7.63 Million
143,542 Added 90.77%
301,688 $14.9 Million
Q3 2022

Nov 10, 2022

SELL
$31.97 - $49.37 $495,982 - $765,926
-15,514 Reduced 8.93%
158,146 $5.14 Million
Q2 2022

Aug 10, 2022

SELL
$35.61 - $76.23 $2.8 Million - $5.99 Million
-78,590 Reduced 31.16%
173,660 $6.84 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $4.91 Million - $7.04 Million
-85,247 Reduced 25.26%
252,250 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $2.64 Million - $3.67 Million
36,430 Added 12.1%
337,497 $26.3 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $8.21 Million - $11.3 Million
90,949 Added 43.28%
301,067 $28.7 Million
Q2 2021

Aug 13, 2021

SELL
$93.66 - $139.27 $5.59 Million - $8.32 Million
-59,715 Reduced 22.13%
210,118 $26.1 Million
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $2.3 Million - $3.06 Million
19,719 Added 7.88%
269,833 $35.6 Million
Q4 2020

Feb 11, 2021

SELL
$99.61 - $142.12 $1.89 Million - $2.7 Million
-19,009 Reduced 7.06%
250,114 $33.1 Million
Q3 2020

Nov 12, 2020

SELL
$72.92 - $102.01 $1.52 Million - $2.13 Million
-20,854 Reduced 7.19%
269,123 $27.4 Million
Q2 2020

Jul 31, 2020

SELL
$55.75 - $92.75 $5.83 Million - $9.7 Million
-104,577 Reduced 26.51%
289,977 $25.2 Million
Q1 2020

May 01, 2020

BUY
$37.9 - $104.44 $3.98 Million - $11 Million
105,077 Added 36.3%
394,554 $22.9 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $3.24 Million - $4.16 Million
-41,753 Reduced 12.61%
289,477 $26.8 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $518,362 - $702,602
5,736 Added 1.76%
331,230 $29.9 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $6.97 Million - $9.2 Million
77,920 Added 31.47%
325,494 $38.4 Million
Q1 2019

May 14, 2019

SELL
$61.98 - $96.5 $4.93 Million - $7.68 Million
-79,589 Reduced 24.33%
247,574 $21.4 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $10.8 Million - $15.9 Million
191,977 Added 142.01%
327,163 $20.6 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $1.48 Million - $2.47 Million
30,606 Added 29.27%
135,186 $10.7 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $3.46 Million - $6.4 Million
-91,467 Reduced 46.66%
104,580 $6.25 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $2.55 Million - $3.69 Million
64,137 Added 48.62%
196,047 $7.91 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $2.11 Million - $2.74 Million
-45,354 Reduced 25.59%
131,910 $6.93 Million
Q3 2017

Nov 14, 2017

SELL
$37.05 - $47.12 $47.6 Million - $60.6 Million
-1,285,801 Reduced 87.88%
177,264 $8.35 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,354,760 Added 1250.87%
1,463,065 $51.7 Million
Q1 2017

Nov 14, 2017

BUY
N/A
108,305
108,305 $2.56 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.